Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Bone Biologics Corporation
Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
August 02, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
BBLGW
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
June 20, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
BBLGW
Bone Biologics Announces Closing of $2.0 Million Public Offering
March 06, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Announces Pricing of $2.0 Million Public Offering
March 04, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Reports Progress With NB1 Clinical Program
March 01, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
January 11, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
BBLGW
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
January 10, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
BBLGW
Bone Biologics Announces 1-for-8 Reverse Stock Split
December 18, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
BBLGW
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 16, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Prices $5.0 Million Underwritten Public Offering
June 14, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Effects 1-for-30 Reverse Stock Split
June 06, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
April 11, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization
January 26, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics CEO Issues Letter to Stockholders
October 25, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering
October 12, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering
October 07, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
March 23, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference
January 05, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright